Will Direct Oral Anticoagulants Have a Chance in Prosthetic Valves?
Although there are abundant data highlighting the safety and efficacy of direct oral anticoagulants, to date, recent guidelines have limited their use to stroke prevention in patients with non-valvular AF, as well as in the prevention and treatment of venous thromboembolism and pulmonary embolism. E...
Guardado en:
Autores principales: | Mahmoud Abdelnabi, Abdallah Almaghraby, Yehia Saleh |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Radcliffe Medical Media
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3f7a0c0fc0ee4d7b98debbb323263092 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Coronavirus Disease 2019 Myocarditis: Insights into Pathophysiology and Management
por: Mahmoud Abdelnabi, et al.
Publicado: (2020) -
Ivabradine and AF: Coincidence, Correlation or a New Treatment?
por: Mahmoud Abdelnabi, et al.
Publicado: (2020) -
Relationship between silent cerebral infarcts and quality of anticoagulation in patients with prosthetic mitral valves
por: Nil Özyüncü, et al.
Publicado: (2021) -
Direct Oral Anticoagulants Concentration Testing in Clinical Practice for High-Risk Patients with AF
por: K Pukite, et al.
Publicado: (2020) -
Direct-acting Anticoagulants in Chronic Coronary Syndromes
por: Emmanuel Sorbets, et al.
Publicado: (2020)